Skip to menu Skip to content Skip to footer

2017

Conference Publication

Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy

Thomas, S., Schaider, H., Laino, A., Adams, L. and Soyer, P. (2017). Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652

Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy

2016

Conference Publication

Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity

Nierfeld, M., Nascimento, P. R., Baesler, K., Knuever, J., Spoerri, L., Schaider, H., Weninger, W. and Haass, N. K. (2016). Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity

2016

Conference Publication

Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?

Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins.

Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?

2016

Conference Publication

Global histone modifications define early stress induced drug tolerance in cancer

Al Emran, Abdullah, Menon, Dinoop Ravindran, Soyer, Peter, Gabrielli, Brian, Sturm, Rick, Herlyn, Meenhard and Schaider, Helmut (2016). Global histone modifications define early stress induced drug tolerance in cancer. American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA, United States, 24-27 September 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.CHROMEPI15-B34

Global histone modifications define early stress induced drug tolerance in cancer

2016

Conference Publication

Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma

Menon, D. R., Hammerlindl, H., Emran, A., Thakkar, D., Soyer, H. P., Herlyn, M., Krepler, C. and Schaider, H. (2016). Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.

Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma

2016

Conference Publication

Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model

Ahmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584

Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model

2016

Conference Publication

Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma

Schaider, H., Menon, D. R., Emran, A., Gabrielli, B., Haass, N., Somasundaram, R. and Herlyn, M. (2016). Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, 18-21 November 2014. Richmond, VIC Australia: Wiley-Blackwell .

Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma

2016

Conference Publication

Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer

Emran, A. A., Menon, D. R., Marzese, D., Hammerlindl, H., Brafford, P., Stark, M., Huang, S., Hammerlindl, S., Gupta, D., Soyer, P., Sturm, R., Hoon, D., Gabrielli, B., Herlyn, M. and Schaider, H. (2016). Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.

Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer

2016

Conference Publication

Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma

Hammerlindl, H., Rad, E. B., Menon, D. R., Hafner, C., Herlyn, M. and Schaider, H. (2016). Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.

Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma

2015

Conference Publication

An early innate stress response precedes acquired drug resistance in melanoma

Menon, Dinoop Ravindran, Das, Suman, Krepler, Clemens, Vultur, Adina, Zhang, Gao, Haass, Nikolas, Soyer, Peter H., Gabrielli, Brian, Somasundaram, Rajasekharan, Hoefler, Gerald, Herlyn, Meenhard and Schaider, Helmut (2015). An early innate stress response precedes acquired drug resistance in melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia Pa United States, April 18-22, 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-2684

An early innate stress response precedes acquired drug resistance in melanoma

2015

Conference Publication

Molecular profiles of reticular and globular naevus patterns: a pilot study

Ong, N., Duffy, D., Leikvold, A., Lee, K., Jagirdar, K., Lin, Lynlee L., Yamada, M., Sturm, R. A., Prow, T. W., Schaider, H. and Soyer, H. P. (2015). Molecular profiles of reticular and globular naevus patterns: a pilot study. 48th Annual Scientific Meeting of the Australasian College of Dermatologists, Adelaide SA, Australia, 16 May 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337

Molecular profiles of reticular and globular naevus patterns: a pilot study

2015

Conference Publication

Feasibility of genotyping melanocytic lesions by microsampling

Tan, Jean-Marie, Lin, Lynlee L., Lambie, Duncan, Ong, Natalie, Flewell-Smith, Ross, Jagirdar, Kasturee, Schaider, Helmut, Sturm, Richard A., Prow, Tarl W. and Soyer, H. Peter (2015). Feasibility of genotyping melanocytic lesions by microsampling. 73rd Annual Meeting of the American Academy of Dermatology, San Francisco, California, 20–24 March 2015. Philadelphia, PA United States: Mosby.

Feasibility of genotyping melanocytic lesions by microsampling

2015

Conference Publication

The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome

Troppan, Katharina, Wenzl, Kerstin, Neumeister, Peter, Beham-Schmid, Christine, Przekopowitz, Martina, Greinix, Hildegard T., Schaider, Helmut and Deutsch, Alexander J. A. (2015). The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome. 55th Annual Meeting and Exposition of the American-Society-of-Hematology, New Orleans LA, United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology.

The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome

2015

Conference Publication

Notch4 drives mesenchymal-epithelial transition in melanoma

Rad, E. Bonyadi, Hammerlindl, H., Wels, C., Menon, D., Soyer, H. P., Bergler, H. and Schaider, H. (2015). Notch4 drives mesenchymal-epithelial transition in melanoma. 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623

Notch4 drives mesenchymal-epithelial transition in melanoma

2014

Conference Publication

A stress induced early innate response causes multi-drug tolerance in melanoma

Menon, D. R., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2014). A stress induced early innate response causes multi-drug tolerance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, Nov 18-21, 2014. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(14)70219-9

A stress induced early innate response causes multi-drug tolerance in melanoma

2014

Conference Publication

Human lactoferricin derivatives as new targeted weapons in cancer therapy

Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Human lactoferricin derivatives as new targeted weapons in cancer therapy. 58th Annual Meeting of the Biophysical-Society, San Francisco United States, Feb 15-19, 2014. St. Louis, United States: Cell Press. doi: 10.1016/j.bpj.2013.11.554

Human lactoferricin derivatives as new targeted weapons in cancer therapy

2014

Conference Publication

Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells

Troppan, K. T., Wenzl, K., Pursche, B., Schaider, H., Beham-Schmid, C., Deutsch, A. and Neumeister, P. (2014). Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, Germany, 10-14 October 2014. Basel, Switzerland: S. Karger AG. doi: 10.1159/000368945

Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells

2014

Conference Publication

The intracellular domain of Notch4 suppresses Twist1 and Slug through activation of Hey-1 and Hey-2

Rad, E. Bonyadi, Hammerlindl, H., Menon, D. R., Soyer, H. P., Bergler, H. and Schaider, H. (2014). The intracellular domain of Notch4 suppresses Twist1 and Slug through activation of Hey-1 and Hey-2. 41st Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Cologne, Germany, 13-15 March 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12314

The intracellular domain of Notch4 suppresses Twist1 and Slug through activation of Hey-1 and Hey-2

2014

Conference Publication

Interaction of an antitumor peptide with lipids of the cancer plasma membrane - Formation of membrane domains and influence of cholesterol

Riedl, Sabrina, Rinner, Beate, Rechberger, Gerald, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Interaction of an antitumor peptide with lipids of the cancer plasma membrane - Formation of membrane domains and influence of cholesterol. 58th Annual Meeting of the Biophysical-Society, San Francisco United States, Feb 15-19, 2014. St. Louis, United States: Cell Press. doi: 10.1016/j.bpj.2013.11.558

Interaction of an antitumor peptide with lipids of the cancer plasma membrane - Formation of membrane domains and influence of cholesterol

2014

Conference Publication

Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival

Wenzl, K., Troppan, K., Pursche, B., Schaider, H., Beham-Schmid, C., Deutsch, A. and Neumeister, P. (2014). Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg Germany, 10-14 October 2014. Basel, Switzerland: S Karger AG. doi: 10.1159/000368945

Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival